Objectives of the Study:
- To define, describe, segment, and forecast the global cell viability assays market by product, application, cell type, end user, and region.
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the cell viability assays market in five main regions (along with major countries) North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
- To profile key players in the global cell viability assays market and comprehensively analyze their core competencies and market shares.
- To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global cell viability assays market
Read More Details, Here | Download the PDF Brochure@ http://bit.ly/2IPxBZL
:Market Dynamics:
Major Industry Growth Drivers:
# Rising Incidence and Prevalence of Chronic and Infectious Diseases
# Growing Availability of Funds for Research
# Rising Demand for Cell-Based Assays in Research
# Increasing Focus on the Development of Cell-Based Therapeutics
Major Growth Restraint:
# High Cost of Instruments
Global Growth Opportunities:
# Emerging Markets
# Growing Focus on Stem Cell Research
:Geographical Look-Out:
North America to dominate the market in 2018
North America is expected to account for the largest share of the cell viability assays market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and the high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell viability assays market. Moreover, a number of major global players are based in the US, owing to which, the US is a center for innovation in the cell viability assays market.
:Major Industry Leaders:
The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
Read the Detailed Article on “Cell Viability Assays Market – Global Forecast to 2023”, Here..!
